Adheris Health Q3 Revenue Dip, Stock Falls

Adheris Health reported Q3 FY2026 revenue of AUD 5.4 million, down year‑on‑year, with gross profit AUD 2.1 million and 39% margin.
Cash flow improved modestly, ending the quarter with AUD 9.4 million cash and operating expenditure net after collections of negative AUD 4.6 million.
Shares dropped over 10% to AUD 0.017, a 80% decline over the past year, leaving market cap around $7.8 million.
Management outlined cost‑reduction initiatives, digital platform upgrades, and a goal to achieve cash‑flow neutral Q4 FY2026 and profitability in FY2027.